Source: International Congress 2016 – ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II



Rating:

Share or cite this content

Citations should be made in the following way:
José Carlos Machado (Porto, Portugal). Lung cancer, noninvasive molecular treatment and monitoring. International Congress 2016 – ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer investigations and treatment Source: Breathe 2011; 7: 313-314 Year: 2011 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Source: Eur Respir J 2002; 20: 464-479 Year: 2002 Lung cancer: screening and staging Source: Eur Respir Monogr 2015; 70: 47-59 Year: 2015 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Evaluation of spirometry test as monitoring tool in lung cancer patients Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Lung cancer screening Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Lung cancer screening Source: Guideline 2015 Year: 2015 Lung cancer screening Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018